Price prediction
Novo Nordisk A/S Price Prediction
Will Novo Nordisk A/S (NVO) go up or down? Here is the Novo Nordisk A/S price prediction and forecast for 2026, 2030, 2035 and 2040, combining AI price targets from Grok, ChatGPT and Claude, the Wall Street analyst consensus price target and rating, and a live community forecast. Opinions only, not financial advice.
Preview: sample forecasts shown while the live AI prediction feed is being wired up.
Novo Nordisk A/S AI Price Prediction
Sample AI forecasts
Grok (xAI), ChatGPT (OpenAI) and Claude (Anthropic) give Novo Nordisk A/S (NVO) a 2026 price target, averaging $60.53 (+22.3% versus the current price). Each model's reasoning is below; switch the horizon to see the NVO price prediction for 2026, 2030, 2035 and 2040.
Grok
xAI
End of 2026 target
$66.80 +35.0%
Grok leans bullish: momentum and NVO social volume are building near term, and it sees the long-run trend compounding higher.
ChatGPT
OpenAI
End of 2026 target
$60.37 +22.0%
ChatGPT expects a steady grind higher for NVO: constructive over time, with overhead resistance capping the near-term upside.
Claude
Anthropic
End of 2026 target
$54.43 +10.0%
Claude is cautious near term on stretched positioning, but turns constructive on NVO over multi-year horizons.
Novo Nordisk A/S Analyst Forecast and Price Target
From the latest Wall Street analyst consensus
The Wall Street analyst price target and consensus rating for Novo Nordisk A/S (NVO), currently $45.00, built from buy, hold and sell ratings and 12-month price targets.
Analyst consensus
Wall Street analysts
End of 2026 target
$45.00 -9.1%
Wall Street's 12-month consensus for NVO is 45 (-9% to target), from 7 analysts. Rolling that forward on analysts' own EPS estimates gives about 58 by 2030 (27.95 EPS at the consensus 2x multiple), held past 2030 beyond their coverage.
Novo Nordisk A/S Community Price Prediction
Updates live as CFGI members vote and add targets
What the CFGI community forecasts for Novo Nordisk A/S (NVO) by 2026, with a median NVO target of $60.53. Add your own Novo Nordisk A/S price prediction and vote bullish, neutral or bearish below.
Community
CFGI voters
End of 2026 target
$60.53 +22.3%
Where the CFGI community is leaning for NVO: seeded from the AI average, then updated live as members vote and add price targets. Add yours below.
Add your forecast
Your call on Novo Nordisk A/S by 2026?
2026Novo Nordisk A/S Price Prediction 2026
By the end of 2026, the average Novo Nordisk A/S (NVO) price prediction is $60.53 (+22% versus the current price), with targets ranging from a bearish $45.00 to a bullish $66.80. Near-term, it tracks earnings, rate expectations and the broader market. Switch the horizon above to compare each model's 2026 NVO target.
Novo Nordisk A/S Price Prediction 2030
By the end of 2030, the average Novo Nordisk A/S (NVO) price prediction is $102.38 (+107% versus the current price), with targets ranging from a bearish $58.39 to a bullish $129.00. A 2030 view leans on sustained earnings growth and is far less certain than the 2026 one. Switch the horizon above to compare each model's 2030 NVO target.
Novo Nordisk A/S Price Prediction 2035
By the end of 2035, the average Novo Nordisk A/S (NVO) price prediction is $166.67 (+237% versus the current price), with targets ranging from a bearish $58.39 to a bullish $223.00. By 2035 the range widens sharply, hinging on Novo Nordisk A/S's role in the stock landscape a decade out. Switch the horizon above to compare each model's 2035 NVO target.
Novo Nordisk A/S Price Prediction 2040
By the end of 2040, the average Novo Nordisk A/S (NVO) price prediction is $232.67 (+370% versus the current price), with targets ranging from a bearish $58.39 to a bullish $322.00. A 2040 NVO target is highly speculative, a best-case scenario rather than a base-case forecast. Switch the horizon above to compare each model's 2040 NVO target.
How High Can Novo Nordisk A/S Go?
The most bullish Novo Nordisk A/S (NVO) forecast on this page is $232.67 by 2040, with the bull case for 2026 near $66.80. How high Novo Nordisk A/S can actually go depends on earnings growth, valuation and the wider market, so treat the highest NVO targets as a best case, not a base case. For the downside, the most bearish 2026 forecast here is $45.00.
Will Novo Nordisk A/S Go Up or Down?
Looking to the end of 2026, the AI models lean bullish on Novo Nordisk A/S (NVO), with an average NVO target of $60.53. Whether Novo Nordisk A/S goes up or down from here comes down to momentum, liquidity and macro conditions, and no forecast is certain. For a live read on whether the market is fearful or greedy on Novo Nordisk A/S right now, see the Novo Nordisk A/S Fear and Greed Index.
Is Novo Nordisk A/S a Good Investment?
No price prediction can tell you whether Novo Nordisk A/S (NVO) is a good investment. The targets on this page are opinions, and stock markets can move against even a strong consensus. What they do give you is a range: a bullish case near $66.80 and a bearish case near $45.00 for 2026, with a middle path between. Weigh that against your own time horizon and risk tolerance, and never invest more than you can afford to lose. This is not financial advice.
How Accurate Are Novo Nordisk A/S Price Predictions?
No model or analyst can reliably predict the Novo Nordisk A/S price, and accuracy falls the further out the forecast goes: a 2026 NVO target is far more grounded than a 2040 one. We log every AI and analyst forecast over time, so the Novo Nordisk A/S prediction track record can be checked against what actually happened. Confidence scores show how strongly each model holds its view, not the probability of being right. Markets routinely defy forecasts, so use these as one input among many and never trade on a NVO prediction alone.
How Is the Novo Nordisk A/S Price Prediction Calculated?
Each day we ask three leading AI models, Grok (xAI), ChatGPT (OpenAI) and Claude (Anthropic), for a Novo Nordisk A/S (NVO) price target at every horizon, anchored to the live price. We pair that with the Wall Street analyst consensus price target and rating, and the community forecast adds a live member vote and median price target. Explore the rest of the Novo Nordisk A/S data: the live NVO price, trading volume, price history and latest news, the stock market, and the Novo Nordisk A/S Fear and Greed Index.
Frequently asked questions
What is the Novo Nordisk A/S price prediction for 2026?
What is the Novo Nordisk A/S price prediction for 2030?
Will Novo Nordisk A/S go up?
Is Novo Nordisk A/S a good investment?
How high can Novo Nordisk A/S go?
Are AI Novo Nordisk A/S price predictions accurate?
How are Novo Nordisk A/S price predictions made?
These are AI and analyst opinions and a community poll, not financial advice. Price forecasts are frequently wrong and grow less certain the further out they go; never trade on them alone.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.